Loading…
Reported covered position: DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer Sr. Adv/Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs; SBA-Cong. & Public Liaison; Sen. Feinstein-Jud. Counsel; Jordan Immigration Commission-Legal Counsel
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); HR 3927, Made in America Act; and issues related to Pfizer's operational performance, investments, and the COVID-19 vaccine.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); and operational performance, investments, and the COVID-19 vaccine.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WALMART INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Immigration reform proposals.
Issues pertaining to COVID-19
Discussions regarding S.1260, The United States Innovation and Competition Act, and HR 4001, related to the enforcement of country-of-origin labeling on product listing pages.
Source: Senate LDA
| NIKE, Inc. |
| 12 |
| 2018–2021 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 12 | 2018–2021 |
| VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES | 12 | 2018–2021 |
| PFIZER, INC. | 11 | 2019–2021 |
| WALMART INC | 11 | 2018–2021 |
| AMERICAN AIRLINES INC. | 9 | 2018–2020 |
| CRISPR THERAPEUTICS, INC. | 8 | 2019–2021 |
| THE COCA-COLA COMPANY | 2 | 2021 |
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
American Rescue Plan Act of 2021; issues related to COVID 19; drug pricing (including HR 3); issues related to the Trade-Related Aspects of Intellectual Property Rights Agreement (TRIPS); health disparities among minority populations; and supply chain issues pertaining to the pharmaceutical industry.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); HR 3927, Made in America Act; and issues related to Pfizer's operational performance, investments, and the COVID-19 vaccine.
Issues related to COVID-19; drug pricing (including HR 3); and Most Favored Nation (MFN) proposed rule.
Issues related to COVID-19; drug pricing (including HR 3); and budget reconciliation provisions related to the pharmaceutical industry.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
American Rescue Plan Act of 2021; Omni/COVID-19 Bill; drug pricing (HR 3); and issues related to Hepatitis.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); and operational performance, investments, and the COVID-19 vaccine.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Drug pricing (HR 3); issues related to Hepatitis; and Budget Reconciliation provisions related to the pharmaceutical industry.
American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); HR 3927, Made in America Act; and issues related to Pfizer's operational performance, investments, and the COVID-19 vaccine.
Online Retailer Product Origin Disclosure Act
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding S.1260, The United States Innovation and Competition Act, and HR 4001, related to the enforcement of country-of-origin labeling on product listing pages.
Expanding Medical Education Act
Client: MEHARRY MEDICAL COLLEGE · Firm: EMPIRE CONSULTING GROUP
Issues related to funding of Historically Black Colleges; HR 801-Expanding Medical Education Act; and issues pertaining to COVID-19.
Expanding Medical Education Act
Client: MEHARRY MEDICAL COLLEGE · Firm: EMPIRE CONSULTING GROUP
Issues related to funding of Historically Black Colleges & Universities; HR 801-Expanding Medical Education Act; health disparities among minority populations; issues pertaining to COVID-19; and Budget Reconciliation provisions affecting client.
United States Innovation and Competition Act of 2021
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding S.1260, The United States Innovation and Competition Act, and HR 4001, related to the enforcement of country-of-origin labeling on product listing pages.
Issues related to the deployment of 5G; spectrum policy; Emergency Broadband Benefit Program; LIFT Act; S.2729, the Device Access for Every American Act; and issues related to the National Defense Authorization Act.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); HR 3927, Made in America Act; and issues related to Pfizer's operational performance, investments, and the COVID-19 vaccine.
Protecting Seniors Through Immunization Act of 2021
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to COVID-19; American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); and operational performance, investments, and the COVID-19 vaccine.
Patient Protection and Affordable Care Enhancement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule; HR-4710-Pharmaceutical Independence Long-Term Readiness Act; issues related to health disparities; The Affordable COVID 19 Drug Pricing Act; BioMedical Taxpayer Investment Act; HR 7062-Affordable Insulin for the COVID-19 Emergency Act; S.3780-Help Onshore Manufacturing Efficiencies for Drugs & Devices Act (HOME Act); HR 1425-The Patient Protection & Affordable Care Enhancement Act.
Moving Forward Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues related to 5G; Issues related to COVID-19 including wireless connectivity; the Lifeline Program; the FCC Pledge on Broadband Service; HR 2-Investing in a New Vision for the Environment & Surface Transportation in America Act ("Moving Forward Act").
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; FCC Pledge on Broadband Service; issues related to diversity in programming, issues related to privacy; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Invest in a New Vision for the Environment & Surface Transportation in America Act ("Moving Forward Act").
Issues and proposals related to COVID-19 impacting the aviation industry; S.3730-Registered Travelers Act of 2020; TSA temperature checks; issues related to aviation safety; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"); and the economic, operational and management performance of American Airlines.
Issues relating to Twin 33; HR 2 Investing in a New Vision for the Environment & Surface Transportation in America ("Moving Forward Act").
Issues related to 5G; the E-Rate Program; the FCC Pledge on Broadband Service; the Lifetime Program; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"; issues related to the National Defense Authorization Act.
Issues relating to prescription drug pricing; issues relating to drug shortages; HR 5097-Protecting Seniors Through Immunizations Act; and issues relating to the coronavirus.
HR 5170-Safe Skies Act; pilot flight and duty time rules; and Coronavirus Aid, Relief and Economic Security Act (CARES Act) provisions pertaining to the aviation industry.
HR 6210/S.3471-Uyghur Forced Labor Prevention Act
Affordable Insulin for the COVID–19 Emergency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule; HR-4710-Pharmaceutical Independence Long-Term Readiness Act; issues related to health disparities; The Affordable COVID 19 Drug Pricing Act; BioMedical Taxpayer Investment Act; HR 7062-Affordable Insulin for the COVID-19 Emergency Act; S.3780-Help Onshore Manufacturing Efficiencies for Drugs & Devices Act (HOME Act); HR 1425-The Patient Protection & Affordable Care Enhancement Act.
Issues related to 5G; the E-Rate Program; the FCC Pledge on Broadband Service; the Lifetime Program; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"; issues related to the National Defense Authorization Act.
Accessible, Affordable Internet for All Act
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; FCC Pledge on Broadband Service; issues related to diversity in programming, issues related to privacy; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Invest in a New Vision for the Environment & Surface Transportation in America Act ("Moving Forward Act").
Issues relating to health, sports and fitness; HR 748/S.3548-Coronavirus Aid, Relief & Economic Security Act (CARES Act); and the economic, operational, and management performance of Nike.
Issues related to 5G; S.3398, the EARN Act (establishing a national commission on online child sex exploitation prevention and related purposes); and Coronavirus Aid, Relief and Economic Stability Act (CARES Act) provisions pertaining to communications.
HR 6210/S.3471-Uyghur Forced Labor Prevention Act
Issues relating to health, sports and fitness; HR 748/S.3548-Coronavirus Aid, Relief & Economic Security Act (CARES Act); and the economic, operational, and management performance of Nike.
Issues related to 5G; the E-Rate Program; the FCC Pledge on Broadband Service; the Lifetime Program; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"; issues related to the National Defense Authorization Act.
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; FCC Pledge on Broadband Service; issues related to diversity in programming, issues related to privacy; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Invest in a New Vision for the Environment & Surface Transportation in America Act ("Moving Forward Act").
Issues and proposals related to COVID-19 impacting the aviation industry; S.3730-Registered Travelers Act of 2020; TSA temperature checks; issues related to aviation safety; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"); and the economic, operational and management performance of American Airlines.
HOME Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule; HR-4710-Pharmaceutical Independence Long-Term Readiness Act; issues related to health disparities; The Affordable COVID 19 Drug Pricing Act; BioMedical Taxpayer Investment Act; HR 7062-Affordable Insulin for the COVID-19 Emergency Act; S.3780-Help Onshore Manufacturing Efficiencies for Drugs & Devices Act (HOME Act); HR 1425-The Patient Protection & Affordable Care Enhancement Act.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 1046, Medicare Negotiation and Competitive Licensing Act; HR 3379, Price Relief, Innovation & Competition for Essential Drugs; 1499, Protecting Consumer Access to Generic Drugs; proposed rule to remove, for Medicare Part D and Medicaid managed care programs, the safe harbor exemption for rebates; HR 2113, Prescription Drug STAR Act.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to biosimilars, PBM Patient Cost Sharing, prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.
Medicare Negotiation and Competitive Licensing Act of 2019
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 1046, Medicare Negotiation and Competitive Licensing Act; HR 1499, Protecting Consumer Access to Generic Drugs; Medicare Part B Rebate Rule.
Protecting Consumer Access to Generic Drugs Act of 2019
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 1046, Medicare Negotiation and Competitive Licensing Act; HR 1499, Protecting Consumer Access to Generic Drugs; Medicare Part B Rebate Rule.
Issues relating to Net Neutrality, HR 2036/S.918-E-FRONTIER Act; robocalls; the Nat'l Defense Authorization Act Sec.214; 24 GHz auction/weather forecasting data; S.893-5G small cell legislation.
HR 2036/S.918-E-FRONTIER Act; TRACED Act; Nat'l Defense Authorization Act Sec.214; resiliency/WEA earthquake notifications; contraband phone legislation; S.893-5G small cell legislation; and issues related to privacy.
E-FRONTIER Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, 5G, privacy, "robocalls", HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020, and Huawei patent issue.
Issues relating to Net Neutrality, privacy, cyber-security, and infrastructure proposals; HR 530-Accelerating Broadband Development by Empowering Local Communities Act; HR 2063/S.918, E-FRONTIER Act; robocalls; TRACE Act; HR 2500, the Nat'l Defense Authorization Act for 2020.
E-FRONTIER Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, privacy, "robocalls", and patents for telecommunications; HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020; HR 530, Accelerating Broadband Development by Empowering Local Communities Act of 2019 (5G small cell sites).
Prescription Drug STAR Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 1046, Medicare Negotiation and Competitive Licensing Act; HR 3379, Price Relief, Innovation & Competition for Essential Drugs; 1499, Protecting Consumer Access to Generic Drugs; proposed rule to remove, for Medicare Part D and Medicaid managed care programs, the safe harbor exemption for rebates; HR 2113, Prescription Drug STAR Act.
Eliminating Debtor’s Prison for Kids Act of 2019
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
HR 2300, Nat'l Defense Authorization Act for FY 2020 regarding modernizing the federal procurement process.
National Defense Authorization Act for Fiscal Year 2020
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, privacy, "robocalls", and patents for telecommunications; HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020; HR 530, Accelerating Broadband Development by Empowering Local Communities Act of 2019 (5G small cell sites).
National Defense Authorization Act for Fiscal Year 2020
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, privacy, cyber-security, and infrastructure proposals; HR 530-Accelerating Broadband Development by Empowering Local Communities Act; HR 2063/S.918, E-FRONTIER Act; robocalls; TRACE Act; HR 2500, the Nat'l Defense Authorization Act for 2020.
National Defense Authorization Act for Fiscal Year 2020
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, 5G, privacy, "robocalls", HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020, and Huawei patent issue.
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing, HR 3-Lower Drug Costs Now Act; HR 2693-To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to drug pricing, HR 3-Lower Drug Costs Now Act; HR 2693-To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement; federal budget caps/debt limit.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to prescription drug pricing; patient smoothing legislation; and HR 3-"Lower Drug Costs Now Act."
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 3, Lower Drug Costs Now Act of 2019; Federal budget caps and debt limit; drug importation; patient cost smoothing legislation.
Issues relating to prescription drug pricing, HR 3-Lower Drug Costs Now Act; HR 2693-To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); HR 3, Lower Drug Costs Now Act of 2019; drug importation; patient cost smoothing legislation; S.2543, Prescription Drug Pricing Reduction Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing; HR 3-Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act; and "health extenders"legislation.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to prescription drug pricing; federal budget caps/debt limit; patient smoothing legislation; and HR 3-"Lower Drug Costs Now Act."
Elijah E. Cummings Lower Drug Costs Now Act
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing; federal budget caps/debt limit; HR 3- "Lower Drug Costs Now Act."
Issues relating to drug pricing, HR 3-Lower Drug Costs Now Act; HR 2693-To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement; federal budget caps/debt limit.
HR 3375, Stopping Bad Robocalls Act
HR 3375, Stopping Bad Robocalls Act
HR 3375, Stopping Bad Robocalls Act
PRICED Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 1046, Medicare Negotiation and Competitive Licensing Act; HR 3379, Price Relief, Innovation & Competition for Essential Drugs; 1499, Protecting Consumer Access to Generic Drugs; proposed rule to remove, for Medicare Part D and Medicaid managed care programs, the safe harbor exemption for rebates; HR 2113, Prescription Drug STAR Act.
HR 5170-Safe Skies Act.
Accelerating Broadband Development by Empowering Local Communities Act of 2019
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, privacy, "robocalls", and patents for telecommunications; HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020; HR 530, Accelerating Broadband Development by Empowering Local Communities Act of 2019 (5G small cell sites).
Accelerating Broadband Development by Empowering Local Communities Act of 2019
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, privacy, cyber-security, and infrastructure proposals; HR 530-Accelerating Broadband Development by Empowering Local Communities Act; HR 2063/S.918, E-FRONTIER Act; robocalls; TRACE Act; HR 2500, the Nat'l Defense Authorization Act for 2020.
Accelerating Broadband Development by Empowering Local Communities Act of 2019
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality; HR 530-Accelerating Broadband Development by Empowering Local Communities Act; issues relating to 5G.
Prescription Drug Pricing Reduction Act of 2019
Client: PFIZER INC. · Firm: EMPIRE CONSULTING GROUP
Issues relating to prescription drug pricing; HR 3-Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act; and "health extenders"legislation.
Prescription Drug Pricing Reduction Act of 2019
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues relating to the Affordable Care Act ("ACA"); HR 3, Lower Drug Costs Now Act of 2019; drug importation; patient cost smoothing legislation; S.2543, Prescription Drug Pricing Reduction Act.
HR 2036/S.918-E-FRONTIER Act; TRACED Act; Nat'l Defense Authorization Act Sec.214; resiliency/WEA earthquake notifications; contraband phone legislation; S.893-5G small cell legislation; and issues related to privacy.
Issues relating to Net Neutrality, HR 2036/S.918-E-FRONTIER Act; robocalls; the Nat'l Defense Authorization Act Sec.214; 24 GHz auction/weather forecasting data; S.893-5G small cell legislation.
E-FRONTIER Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, 5G, privacy, "robocalls", HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020, and Huawei patent issue.
HR 2036/S.918-E-FRONTIER Act; TRACED Act; Nat'l Defense Authorization Act Sec.214; resiliency/WEA earthquake notifications; contraband phone legislation; S.893-5G small cell legislation; and issues related to privacy.
Issues relating to Net Neutrality, privacy, cyber-security, and infrastructure proposals; HR 530-Accelerating Broadband Development by Empowering Local Communities Act; HR 2063/S.918, E-FRONTIER Act; robocalls; TRACE Act; HR 2500, the Nat'l Defense Authorization Act for 2020.
E-FRONTIER Act
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
Issues relating to Net Neutrality, privacy, "robocalls", and patents for telecommunications; HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020; HR 530, Accelerating Broadband Development by Empowering Local Communities Act of 2019 (5G small cell sites).
Issues relating to Net Neutrality, HR 2036/S.918-E-FRONTIER Act; robocalls; the Nat'l Defense Authorization Act Sec.214; 24 GHz auction/weather forecasting data; S.893-5G small cell legislation.
AIRWAVES Act (HR 4953); issues related to net neutrality; issues related to privacy; 5G deployment legislation; issues relating to 911 location accuracy.
Wireless/spectrum policy; H. Res 873-Net Neutrality discharge petition; HR 4953 Airwaves Act; and issues related to privacy.
Wireless/spectrum policy; H. Res 873-Net Neutrality discharge petition; HR 4953 Airwaves Act; issues related to diversity and inclusion; and issues related to privacy.
Health/Sports fitness issues including HR 5138, Bipartisan HSA Improvement Act ("the PHIT Act").
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Client: MEHARRY MEDICAL COLLEGE · Firm: EMPIRE CONSULTING GROUP
HR 6157, FY 2019 Defense-Labor-HHS Appropriations; VA Relocation Agreement; funding for Meharry Mobile Dental Unit and rural health grant programs; DHS biomedical grant/procurement opportunities; VA veterans service provider grant/procurement opportunities; Issues related to higher education policy.
Medicare Negotiation and Competitive Licensing Act of 2018
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to the Affordable Care Act; prescription drug costs/pricing; HR 6505, Medicare Negotiation & Competitive Licensing Act of 2018; 340B Drug Pricing Program; issues relating to opioids; and issues relating to Medicare Part D.
Medicare Negotiation and Competitive Licensing Act of 2018
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to the Affordable Care Act; prescription drug costs/pricing; HR 6505, Medicare Negotiation & Competitive Licensing Act of 2018, and issues relating to Medicare Parts B and D.
Providing for consideration of the joint resolution (H.J. Res. 129) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Restoring Internet Freedom".
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to merger of Charter Communications, Time Warner Cable and Brighthouse Networks; proposals relating to H.Res 873-Net Neutrality discharge petition; issues related to privacy; and issues related to diversity and inclusion.
Providing for consideration of the joint resolution (H.J. Res. 129) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Restoring Internet Freedom".
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
H.Res. 873-Net Neutrality discharge petition; issues related to the integration of new aircraft into the National Airspace System; issues related to privacy; and issues related to FirstNet and Interoperability.
Providing for consideration of the joint resolution (H.J. Res. 129) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Restoring Internet Freedom".
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: EMPIRE CONSULTING GROUP
H. Res. 873 - Net Neutrality discharge petition; issues related to spectrum policy; issues related to privacy; and issues related to diversity and inclusion.
Providing for consideration of the joint resolution (H.J. Res. 129) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Restoring Internet Freedom".
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to merger of Charter Communications, Time Warner Cable and Brighthouse Networks; H.Res 873-Net Neutrality discharge petition; and issues related to privacy.
Providing for consideration of the joint resolution (H.J. Res. 129) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Restoring Internet Freedom".
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Wireless/spectrum policy; H. Res 873-Net Neutrality discharge petition; HR 4953 Airwaves Act; and issues related to privacy.
Providing for consideration of the joint resolution (H.J. Res. 129) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Restoring Internet Freedom".
Client: CTIA · Firm: EMPIRE CONSULTING GROUP
Wireless/spectrum policy; H. Res 873-Net Neutrality discharge petition; HR 4953 Airwaves Act; issues related to diversity and inclusion; and issues related to privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to broadband policy; infrastructure proposals; FCC Pledge; Emergency Broadband Benefit Program; and issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Drug pricing (HR 3); issues related to Hepatitis; and Budget Reconciliation provisions related to the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
American Rescue Plan Act of 2021; issues related to COVID 19; drug pricing; health disparities among minority populations; and Medicare rebate rule.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · 3T
Issues pertaining to cell and gene therapies, and sickle cell disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Infrastructure proposals; issues pertaining to the environment/sustainability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to 5G; Emergency Broadband Benefit Program; E-Rate Program; Infrastructure broadband proposals; and Endless Frontier Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
PFIZER INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Corporate taxation
American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); HR 3927, Made in America Act; and issues related to Pfizer's operational performance, investments, and the COVID-19 vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Infrastructure proposals; issues related to the US Postal Service; climate policy; and OSHA's COVID-19 mandate for Federal contractors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to health, sports, and fitness; issues related to diversity and inclusion; issues pertaining to privacy and cybersecurity; and the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to funding of Historically Black Colleges & Universities; HR 801-Expanding Medical Education Act; health disparities among minority populations; issues pertaining to COVID-19; and Budget Reconciliation provisions affecting client.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
CTIA via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to the deployment of 5G; spectrum policy; Emergency Broadband Benefit Program; LIFT Act; S.2729, the Device Access for Every American Act; and issues related to the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMGEN INC. via EMPIRE CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to COVID-19; drug pricing (including HR 3); and budget reconciliation provisions related to the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Endless Frontier Act and issues related to Walmart operations.
Issues pertaining to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
PFIZER INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Corporate taxation
Issues pertaining to COVID-19; American Rescue Plan Act of 2021; HR 1978/S.912, Protecting Seniors through Immunization; drug pricing (including HR 3); and operational performance, investments, and the COVID-19 vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Infrastructure proposals; issues pertaining to the environment/sustainability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to health, sports, and fitness; issues related to diversity and inclusion; issues pertaining to privacy and cybersecurity; Endless Frontier Act; and the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
American Rescue Plan Act of 2021; Omni/COVID-19 Bill; drug pricing (HR 3); and issues related to Hepatitis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to broadband policy; infrastructure proposals and issues; FCC Pledge; and issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues pertaining to cell and gene therapies, and sickle cell disease.
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
CTIA via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to the deployment of 5G; spectrum policy; infrastructure proposals including LIFT America Act; and antitrust issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to funding of Historically Black Colleges; HR 801-Expanding Medical Education Act; and issues pertaining to COVID-19.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to COVID-19; drug pricing (including HR 3); and Most Favored Nation (MFN) proposed rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
American Rescue Plan Act of 2021; infrastructure proposals and issues; Endless Frontier Act; postal issues; and issues pertaining to climate policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to 5G; FCC Pledge on broadband service; E-Rate Program; infrastructure broadband proposals; and Endless Frontier Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2021 · second_quarter · Q2
American Rescue Plan Act of 2021; issues related to COVID 19; drug pricing (including HR 3); issues related to the Trade-Related Aspects of Intellectual Property Rights Agreement (TRIPS); health disparities among minority populations; and supply chain issues pertaining to the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · 1A
Trade Related Aspects of Intellectual Property Rights (TRIPS) Waiver
Operation, performance, investment, and COVID-19 vaccine; and Average Manufacturer Price (AMP) cap in budget resolution.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to health, sports, and fitness; issues related to diversity and inclusion; and the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to broadband policy and infrastructure; American Rescue Plan Act of 2021; and the merger of Charter Communications, Time Warner Cable and Bright House Networks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
American Rescue Plan Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
Operation, performance, investment, and COVID-19 vaccine; and Average Manufacturer Price (AMP) cap in budget resolution.
Trade Related Aspects of Intellectual Property Rights (TRIPS) Waiver
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
Issues pertaining to cell and gene therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
CTIA via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to 5G, spectrum policy, broadband policy, and infrastructure; E-Rate Program; DOD RFI on Spectrum Use.
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
American Rescue Plan Act of 2021
Issues related to funding of Historically Black Colleges.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
American Rescue Plan Act of 2021; 6 Protected Classes; and drug pricing proposals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
American Rescue Plan Act of 2021; drug pricing proposals; and MFN proposed rule.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
American Rescue Plan Act of 2021; aviation infrastructure; postal issues; issues pertaining to aviation safety; issues pertaining to climate policy; and issues pertaining to multi-employer pension plans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to 5G; FCC Pledge on Broadband Service; E-Rate Program; and DOD RFI on Spectrum Use.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2021 · first_quarter · Q1
American Rescue Plan Act of 2021; drug pricing proposals; 6 Protected Classes; and MFN Proposed Rule.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Reimbursements for cell and gene therapies; and clinical trial results/updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues and proposals related to prescription drug pricing and drug shortages; issues and proposals related to COVID-19 including clinical trials, vaccines and therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues related to the impact of COVID-19 and issues related to Walmart operations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues related to 5G; the E-Rate Program; the FCC Pledge on Broadband Service; the Lifetime Program; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"; issues related to the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Increased funding for COVID-19 testing; other COVID-19-related funding for under-served and rural communities and coordinating with HHS grant programs.
Issues and proposals related to COVID-19 including the disproportionate impact of COVID-19 on communities of color; and Meharry Mobile Dental Unit/Blockchain data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues related to COVID-19; issues related to prescription drug pricing; and diversity in clinical trials.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Medicare Part B coverage of infused and injectable medicines at home during COVID-19 pandemic; issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; FCC Pledge on Broadband Service; issues related to diversity in programming, issues related to privacy; S.3695-CONNECT at Home Act; HR 7302-Accessible, Affordable Internet for All Act; HR 2-Invest in a New Vision for the Environment & Surface Transportation in America Act ("Moving Forward Act").
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues relating to health, sports and fitness; issues pertaining to diversity and inclusion; and the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues relating to Twin 33; HR 2 Investing in a New Vision for the Environment & Surface Transportation in America ("Moving Forward Act").
Issues and proposals related to COVID-19 pertaining to the aviation industry; Pilot flight and duty time rules; issues related to the U.S. Postal Service; and issues related to aviation safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues related to 5G; Issues related to COVID-19 including wireless connectivity; the Lifeline Program; the FCC Pledge on Broadband Service; HR 2-Investing in a New Vision for the Environment & Surface Transportation in America Act ("Moving Forward Act").
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule; HR-4710-Pharmaceutical Independence Long-Term Readiness Act; issues related to health disparities; The Affordable COVID 19 Drug Pricing Act; BioMedical Taxpayer Investment Act; HR 7062-Affordable Insulin for the COVID-19 Emergency Act; S.3780-Help Onshore Manufacturing Efficiencies for Drugs & Devices Act (HOME Act); HR 1425-The Patient Protection & Affordable Care Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2020 · second_quarter · Q2
Issues and proposals related to COVID-19 impacting the aviation industry; S.3730-Registered Travelers Act of 2020; TSA temperature checks; issues related to aviation safety; HR 2-Investing in a New Vision for the Environment & Surface Transportation Act ("Moving Forward Act"); and the economic, operational and management performance of American Airlines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Reimbursements for cell and gene therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues relating to prescription drug pricing; issues relating to drug shortages; HR 5097-Protecting Seniors Through Immunizations Act; and issues relating to the coronavirus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues related to Walmart operations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues related to 5G; S.3398, the EARN Act (establishing a national commission on online child sex exploitation prevention and related purposes); and Coronavirus Aid, Relief and Economic Stability Act (CARES Act) provisions pertaining to communications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Funding for higher education including historically Black colleges and universities and other minority-serving institutions.
Issues relating to the Coronavirus Aid, Relief and Economic Stability Act (CARES Act); and healthcare disparity among minority communities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues related to prescription drug pricing; and issues related to the coronavirus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues relating to prescription drug pricing; and issues relating to the coronavirus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; issues related to diversity in programming, privacy and broadband access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
HR 6210/S.3471-Uyghur Forced Labor Prevention Act
Issues relating to health, sports and fitness; HR 748/S.3548-Coronavirus Aid, Relief & Economic Security Act (CARES Act); and the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
HR 5170-Safe Skies Act; pilot flight and duty time rules; and Coronavirus Aid, Relief and Economic Security Act (CARES Act) provisions pertaining to the aviation industry.
Issues relating to Twin 33.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues relating to 5G; National Defense Authorization Act of FY2020; and Coronavirus Aid, Relief and Economic Security Act (CARES Act) provisions pertaining to telecommunications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Issues relating to drug pricing; 2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule; and issues related to the coronavirus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2020 · first_quarter · Q1
Passenger facility charges (PFC); issues related to aviation safety; Coronavirus Aid, Relief and Economic Security Act (CARES Act) provisions pertaining to aviation industry; and the economic, operational and management performance of American Airlines Inc.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Reimbursements for cell and gene therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
US-Mexico-Canada Agreement.
Issues relating to prescription drug pricing; HR 3-Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act; and "health extenders"legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Issues pertaining to the operational performance of Walmart.
Issues relating to the US-Mexico-Canada Agreement; issues pertaining to privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
HR 2036/S.918-E-FRONTIER Act; TRACED Act; Nat'l Defense Authorization Act Sec.214; resiliency/WEA earthquake notifications; contraband phone legislation; S.893-5G small cell legislation; and issues related to privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Oral and integrative health issues.
Funding for Meharry Mobile Dental Unit; Future Act (funding for historically Black colleges and universities and other minority-serving institutions)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Issues related to prescription drug pricing; patient smoothing legislation; and HR 3-"Lower Drug Costs Now Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
US-Mexico-Canada Agreement
Issues relating to prescription drug pricing, HR 3-Lower Drug Costs Now Act; HR 2693-To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; "robocalls" legislation; issues related to net neutrality, privacy, and diversity in programming.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Issues related to the US-Mexico-Canada Trade Agreement, and the general system of preferences (GSP).
Issues relating to health, sports and fitness; the economic, operational, and management performance of Nike.
Granting Customs Border Protection authority to seize products based on violated design and patent rights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
HR 5170-Safe Skies Act.
HR 3375, Stopping Bad Robocalls Act
Issues relating to Twin 33.
US Mexico Canada Agreement (USMCA).
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
Issues relating to Net Neutrality, 5G, privacy, and "robocalls"; National Defense Authorization Act of FY2020; Huawei patent issue; and Mexico cross-border wireless interference.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
US-Mexico-Canada Agreement
Issues relating to the Affordable Care Act ("ACA"); HR 3, Lower Drug Costs Now Act of 2019; drug importation; patient cost smoothing legislation; S.2543, Prescription Drug Pricing Reduction Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2019 · fourth_quarter · Q4
EU-Airbus tariffs
Passenger facility charges (PFC); issues related to aviation safety and certification processes; tax extenders relating to aviation; economic, operational and management performance of American Airlines Inc.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Reimbursements for cell and gene therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRISPR THERAPEUTICS INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · RR
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
PFIZER INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Issues relating to prescription drug pricing; federal budget caps/debt limit; HR 3- "Lower Drug Costs Now Act."
US-Mexico-Canada Agreement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Discussions relating to increasing the federal minimum wage; investment in associates including workforce training initiatives; and issues pertaining to the operational performance of Walmart.
Issues relating to the US-Mexico-Canada Agreement; issues pertaining to privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Issues relating to Net Neutrality, HR 2036/S.918-E-FRONTIER Act; robocalls; the Nat'l Defense Authorization Act Sec.214; 24 GHz auction/weather forecasting data; S.893-5G small cell legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Oral and integrative health issues; funding for Meharry Mobile Dental Unit; rural health programs' and veterans access to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Issues related to prescription drug pricing; federal budget caps/debt limit; patient smoothing legislation; and HR 3-"Lower Drug Costs Now Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Issues relating to drug pricing, HR 3-Lower Drug Costs Now Act; HR 2693-To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement; federal budget caps/debt limit.
US-Mexico-Canada Agreement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Granting Customs Border Protection authority to seize products based on violated design and patent rights.
Issues related to the US-Mexico-Canada Trade Agreement, and the general system of preferences (GSP).
Issues relating to health, sports and fitness; the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; privacy; net neutrality and diversity and inclusion; "robocalls" legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
HR 3375, Stopping Bad Robocalls Act
US Mexico Canada Agreement (USMCA).
Issues relating to Twin 33; FAA Reauthorization Act of 2018; federal budget caps/debt limit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Issues relating to Net Neutrality, 5G, privacy, "robocalls", HR 2063/S.918, E-FRONTIER Act; HR 2500, Nat'l Defense Authorization Act of FY'2020, and Huawei patent issue.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
US-Mexico-Canada Agreement
Issues relating to the Affordable Care Act ("ACA"); prescription drug costs/pricing; HR 3, Lower Drug Costs Now Act of 2019; Federal budget caps and debt limit; drug importation; patient cost smoothing legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2019 · third_quarter · Q3
Passenger facility charges (PFC); airport infrastructure; federal budget caps/debt limits; issues related to aircraft safety and certification processes; labor-management relations; and economic, operational and management performance of American Airlines.
EU-Airbus tariff
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER INC. via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Issues relating to prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.
Filing targets: HOUSE OF REPRESENTATIVES
WALMART INC. via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
HR 2300, Nat'l Defense Authorization Act for FY 2020 regarding modernizing the federal procurement process.
Issues relating to company investment in associates including workforce training initiatives.
Issues relating to the US-Mexico-Canada Agreement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Issues relating to Net Neutrality, privacy, cyber-security, and infrastructure proposals; HR 530-Accelerating Broadband Development by Empowering Local Communities Act; HR 2063/S.918, E-FRONTIER Act; robocalls; TRACE Act; HR 2500, the Nat'l Defense Authorization Act for 2020.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Oral and integrative health issues; funding for Meharry Mobile Health Unit; rural health grant program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Issues related to prescription drug pricing; Six (6) protected classes.
Filing targets: HOUSE OF REPRESENTATIVES
AMGEN INC. via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Issues relating to biosimilars, PBM Patient Cost Sharing, prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.
Filing targets: HOUSE OF REPRESENTATIVES
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Issues related to the merger of Charter Communications, Time Warner Cable and Bright House Networks; privacy; net neutrality and diversity and inclusion.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2019 · second_quarter · Q2
Issues relating to health, sports and fitness.
US-Mexico-Canada Trade Agreement
Granting Customs Border Protection authority to seize products based on violated design and patent rights.
Filing targets: HOUSE OF REPRESENTATIVES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.